do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation Mechanisms of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, glucagon‐like The Role of DPP-4 Inhibitors
Description
If patients start these medications without changing how they eat, the medications will be less effective, Dr

Back Deacon, DF, Johnsen, AH, Holst, JJ (March 1995) 'Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo', Journal Clinical Endocrinology Metabolism , 80/3, 952-7

The future will usher in multiple new ways of delivering GLP-1 medicines, and activating GLP-1R signaling pathways, promising improved efficacy/convenience

"Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies"

doi: 10.1111/dom.13924